Zogenix, Inc. To Present At The Oppenheimer 24th Annual Healthcare Conference
Published: Dec 04, 2013
SAN DIEGO, Dec. 4, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system disorders and pain, today announced that Ann Rhoads, Chief Financial Officer will present at the Oppenheimer 24th Annual Healthcare Conference in New York on December 11, 2013.
Help employers find you! Check out all the jobs and post your resume.